295 related articles for article (PubMed ID: 34279740)
1. Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases-an updated systematic review.
Senguttuvan NB; Subramanian V; Venkatesan V; Muralidharan TR; Sankaranarayanan K
J Genet Eng Biotechnol; 2021 Jul; 19(1):105. PubMed ID: 34279740
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations.
Calvillo-Argüelles O; Schoffel A; Capo-Chichi JM; Abdel-Qadir H; Schuh A; Carrillo-Estrada M; Liu S; Gupta V; Schimmer AD; Yee K; Shlush LI; Natarajan P; Thavendiranathan P
JACC CardioOncol; 2022 Mar; 4(1):38-49. PubMed ID: 35492819
[TBL] [Abstract][Full Text] [Related]
3. Clonal hematopoiesis of indeterminate potential in patients with acute coronary syndrome undergoing percutaneous coronary intervention in the absence of traditional risk factors.
Jiang Z; Li Y; Yan C; Zhang X; Zhang Q; Li J; Tian X; Qiu M; Liang Z; Ma S; Na K; Li Z; Chen S; Zhao Y; Qi Z; Liu X; Han Y
Clin Res Cardiol; 2023 Apr; 112(4):506-517. PubMed ID: 35704087
[TBL] [Abstract][Full Text] [Related]
4. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
Jaiswal S; Natarajan P; Silver AJ; Gibson CJ; Bick AG; Shvartz E; McConkey M; Gupta N; Gabriel S; Ardissino D; Baber U; Mehran R; Fuster V; Danesh J; Frossard P; Saleheen D; Melander O; Sukhova GK; Neuberg D; Libby P; Kathiresan S; Ebert BL
N Engl J Med; 2017 Jul; 377(2):111-121. PubMed ID: 28636844
[TBL] [Abstract][Full Text] [Related]
5. Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.
Singh I; Singh A
Curr Oncol Rep; 2023 Jun; 25(6):539-547. PubMed ID: 36928826
[TBL] [Abstract][Full Text] [Related]
6. Genetic modification of inflammation- and clonal hematopoiesis-associated cardiovascular risk.
Yu Z; Fidler TP; Ruan Y; Vlasschaert C; Nakao T; Uddin MM; Mack T; Niroula A; Heimlich JB; Zekavat SM; Gibson CJ; Griffin GK; Wang Y; Peloso GM; Heard-Costa N; Levy D; Vasan RS; Aguet F; Ardlie KG; Taylor KD; Rich SS; Rotter JI; Libby P; Jaiswal S; Ebert BL; Bick AG; Tall AR; Natarajan P
J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37498674
[TBL] [Abstract][Full Text] [Related]
7. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
[TBL] [Abstract][Full Text] [Related]
8. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
Dorsheimer L; Assmus B; Rasper T; Ortmann CA; Ecke A; Abou-El-Ardat K; Schmid T; Brüne B; Wagner S; Serve H; Hoffmann J; Seeger F; Dimmeler S; Zeiher AM; Rieger MA
JAMA Cardiol; 2019 Jan; 4(1):25-33. PubMed ID: 30566180
[TBL] [Abstract][Full Text] [Related]
9. Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk.
Tobias DK; Manning AK; Wessel J; Raghavan S; Westerman KE; Bick AG; Dicorpo D; Whitsel EA; Collins J; Correa A; Cupples LA; Dupuis J; Goodarzi MO; Guo X; Howard B; Lange LA; Liu S; Raffield LM; Reiner AP; Rich SS; Taylor KD; Tinker L; Wilson JG; Wu P; Carson AP; Vasan RS; Fornage M; Psaty BM; Kooperberg C; Rotter JI; Meigs J; Manson JE;
Diabetes Care; 2023 Nov; 46(11):1978-1985. PubMed ID: 37756531
[TBL] [Abstract][Full Text] [Related]
10. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM
JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511
[TBL] [Abstract][Full Text] [Related]
11. Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.
Yu B; Roberts MB; Raffield LM; Zekavat SM; Nguyen NQH; Biggs ML; Brown MR; Griffin G; Desai P; Correa A; Morrison AC; Shah AM; Niroula A; Uddin MM; Honigberg MC; Ebert BL; Psaty BM; Whitsel EA; Manson JE; Kooperberg C; Bick AG; Ballantyne CM; Reiner AP; Natarajan P; Eaton CB;
J Am Coll Cardiol; 2021 Jul; 78(1):42-52. PubMed ID: 34210413
[TBL] [Abstract][Full Text] [Related]
12. Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndrome.
Naqvi K; Sasaki K; Montalban-Bravo G; Alfonso Pierola A; Yilmaz M; Short N; Assi R; Jabbour E; Ravandi F; Kadia T; Pierce S; Takahashi K; Nogueras Gonzalez G; Kanagal-Shamanna R; Patel K; Soltysiak KA; Kantarjian HM; Garcia-Manero G
Cancer; 2019 Jul; 125(13):2233-2241. PubMed ID: 30861111
[TBL] [Abstract][Full Text] [Related]
13. Genetic Interleukin 6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis.
Bick AG; Pirruccello JP; Griffin GK; Gupta N; Gabriel S; Saleheen D; Libby P; Kathiresan S; Natarajan P
Circulation; 2020 Jan; 141(2):124-131. PubMed ID: 31707836
[TBL] [Abstract][Full Text] [Related]
14. Clonal Hematopoiesis of Indeterminate Potential: A Multidisciplinary Challenge in Personalized Hematology.
Hoermann G; Greiner G; Griesmacher A; Valent P
J Pers Med; 2020 Aug; 10(3):. PubMed ID: 32825226
[TBL] [Abstract][Full Text] [Related]
15. Leukocytes carrying
von Scheidt M; Bauer S; Ma A; Hao K; Kessler T; Vilne B; Wang Y; Hodonsky CJ; Ghosh SKB; Mokry M; Gao H; Kawai K; Sakamoto A; Kaiser J; Bongiovanni D; Fleig J; Oldenbuettel L; Chen Z; Moggio A; Sager HB; Hecker JS; Bassermann F; Maegdefessel L; Miller CL; Koenig W; Zeiher AM; Dimmeler S; Graw M; Braun C; Ruusalepp A; Leeper NJ; Kovacic JC; Björkegren JLM; Schunkert H
medRxiv; 2023 Jul; ():. PubMed ID: 37546840
[TBL] [Abstract][Full Text] [Related]
16. Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk.
Haring B; Wissel S; Manson JE
Curr Cardiol Rep; 2022 Aug; 24(8):1049-1058. PubMed ID: 35657494
[TBL] [Abstract][Full Text] [Related]
17. High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential.
Busque L; Sun M; Buscarlet M; Ayachi S; Feroz Zada Y; Provost S; Bourgoin V; Mollica L; Meisel M; Hinterleitner R; Jabri B; Dubé MP; Tardif JC
Blood Adv; 2020 Jun; 4(11):2430-2438. PubMed ID: 32492156
[TBL] [Abstract][Full Text] [Related]
18. Clonal hematopoiesis: Genes and underlying mechanisms in cardiovascular disease development.
Haybar H; Shahrabi S; Ghanavat M; Khodadi E
J Cell Physiol; 2019 Jun; 234(6):8396-8401. PubMed ID: 30417440
[TBL] [Abstract][Full Text] [Related]
19. Clonal hematopoiesis and cardiovascular disease: deciphering interconnections.
Stein A; Metzeler K; Kubasch AS; Rommel KP; Desch S; Buettner P; Rosolowski M; Cross M; Platzbecker U; Thiele H
Basic Res Cardiol; 2022 Nov; 117(1):55. PubMed ID: 36355225
[TBL] [Abstract][Full Text] [Related]
20. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
Marnell CS; Bick A; Natarajan P
J Mol Cell Cardiol; 2021 Dec; 161():98-105. PubMed ID: 34298011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
